Amount Raised
$105 Million
Round Type
Series C
AllschwilManufacturingInvestors
Description
Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in a new investment in the US$105 million Series C financing of Alentis Therapeutics, a clinical-stage biotech developing breakthrough treatments for organ fibrosis and Claudin-1 (CLDN1) positive tumors. The financing will support clinical development of Alentis' lead investigational products ALE.F02 and ALE.C04 as well as the CLDN1 platform development.
Quick answer
Alentis Therapeutics raised $105 Million in a Series C round, dated April 13, 2023. Investors: Schroders Capital, Bpifrance, Bb Pureos Bioventures, Novo Holdings A/, Naveed Siddiqi, RA Capital Management, Novo Holdings and Jeito Capital. Alentis Therapeutics is based in Allschwil, Basel-Landschaft, Switzerland.
- How much did Alentis Therapeutics raise?
- Alentis Therapeutics raised $105 Million in a Series C round on April 13, 2023.
- Who invested in Alentis Therapeutics?
- Schroders Capital, Bpifrance, Bb Pureos Bioventures, Novo Holdings A/, Naveed Siddiqi, RA Capital Management, Novo Holdings and Jeito Capital are named as investors in this round.
- What does Alentis Therapeutics do?
- Alentis Therapeutics is a clinical-stage biotechnology company pioneering first-in-class antibody-drug conjugates (ADCs) and antibodies targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis.
- Where is Alentis Therapeutics based and how big is it?
- Alentis Therapeutics is based in Allschwil, Basel-Landschaft, Switzerland. Fundz records about 68 employees.
- Who are the decision-makers at Alentis Therapeutics?
- Fundz holds 1 contact at Alentis Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing around the same time
Companies in the same sectors as Alentis Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Orbion Space Technology raised $7.8M on May 26, 2023.
- Reed’s raised $4.1M (Seed) on May 25, 2023.
- Lyten raised an undisclosed amount (Funding Round) on May 25, 2023.
- Ohanafy raised $2.7M on May 24, 2023.
- EMO.energy raised $1.2M (Seed) on May 23, 2023.
- CleanFiber raised $5M (Seed) on May 19, 2023.
Who to call at Alentis Therapeutics, and when
A new round usually means Alentis Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alentis Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alentis Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alentis Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alentis Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alentis Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.